Astria Therapeutics to Present at Upcoming Western Society of Allergy, Asthma & Immunology Annual Scientific Session
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present quality ...
Astria Therapeutics (NASDAQ:ATXS) Rating Increased to Strong-Buy at Citizens Jmp
Citizens Jmp upgraded shares of Astria Therapeutics (NASDAQ:ATXS – Free Report) to a strong-buy rating in a report published on Friday,Zacks.com reports. Other equities analysts have also recently ...
Astria Therapeutics initiated with an Outperform at JMP Securities
JMP Securities analyst Jonathan Wolleben initiated coverage of Astria Therapeutics (ATXS) with an Outperform rating and $26 price target ...
Buy Rating for Astria Therapeutics: Promising Prospects in HAE and Atopic Dermatitis Markets
Jonathan Wolleben, an analyst from JMP Securities, has initiated a new Buy rating on Astria Therapeutics (ATXS).Invest with Confidence: Follow ...
Fintel on MSN2d
JMP Securities Initiates Coverage of Astria Therapeutics (ATXS) with Market Outperform Recommendation
Fintel reports that on January 31, 2025, JMP Securities initiated coverage of Astria Therapeutics (NasdaqGM:ATXS) with a Market Outperform recommendation. Analyst Price Forecast Suggests 244.82% ...
Investing3d
JMP Securities starts Astria Therapeutics stock at Market Outperform
On Friday, JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a price target of $26.00. The stock, currently trading at $7.49 ...
Investing3d
JMP Securities starts Astria Therapeutics stock at Market Outperform
On Friday, JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a price target of $26.00. The stock, currently trading at $7.49, ...
Nasdaq5d
JMP Securities Initiates Coverage of Astria Therapeutics (ATXS) with Market Outperform Recommendation
Fintel reports that on January 31, 2025, JMP Securities initiated coverage of Astria Therapeutics (NasdaqGM:ATXS) with a Market Outperform recommendation. As of January 29, 2025, the average one ...
ADVFN5d
Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present ...
Le Lézard10h
Pfizer Canada and partners announce quality improvement grant recipients for Canada's most prevalent cancers
This World Cancer Day, Pfizer Canada ULC, together with Rethink Breast Cancer, Colorectal Cancer Canada, Lung Health Foundation, Lung Cancer Canada, and the Quebec Lung Association, is pleased to ...
Le Lézard10h
Biocodex Microbiota Foundation Announces Open Call for Project for $50,000 2025 USA Microbiome Research Grant
The Biocodex Microbiota Foundation, an independent organization founded by Biocodex, has opened applications for its 2025 USA research grant. Now in its 9th year, the $50,000 grant, juried by a panel ...